Table S1.
Complication | Nasal Oxygen |
bCPAP | Transitioned from nasal oxygen to bCPAP |
Mild facial irritation, < 1 day duration | 3 (12%) | 1 (1.9%) | 0 (0.0%) |
Mild nasal irritation, < 3 day duration | 1 (4.0%) | 7 (13.2%) | 2 (22.2%) |
Mild epistaxis | 1 (4.0%) | 6 (11.3%) | 2 (22.2%) |